Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Avatrombopag/hydroxycarbamide

Thrombocytosis and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Sosnovske DE, et al. THROMBOCYTAPHERESIS IN THE MANAGEMENT OF AVATROMBOPAG INDUCED THROMBOCYTOSIS IN A PATIENT WITH ITP. Journal of Clinical Apheresis 38: 334-335, No. 3, Jun 2023. Available from: URL: http://doi.org/10.1002/jca.22049 [abstract] Sosnovske DE, et al. THROMBOCYTAPHERESIS IN THE MANAGEMENT OF AVATROMBOPAG INDUCED THROMBOCYTOSIS IN A PATIENT WITH ITP. Journal of Clinical Apheresis 38: 334-335, No. 3, Jun 2023. Available from: URL: http://​doi.​org/​10.​1002/​jca.​22049 [abstract]
Metadaten
Titel
Avatrombopag/hydroxycarbamide
Thrombocytosis and lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41754-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ascorbic-acid

Case report

Hydroxocobalamin

Case report

Rituximab